Literature DB >> 26799954

Evaluation of protective effects of diosmin (a citrus flavonoid) in chemical-induced urolithiasis in experimental rats.

V Vinoth Prabhu1, D Sathyamurthy1, Anand Ramasamy1, Saibal Das2, Medepalli Anuradha1, Sudhakar Pachiappan1.   

Abstract

Context There have not been any conclusive studies of the effects of diosmin, a modified flavanone glycoside obtained from Teucrium gnaphalodes L'Her (Lamiaceae), on urolithiasis. Objective To evaluate anti-urolithiatic effects of diosmin in ammonium chloride and ethylene glycol-induced renal stone in experimental animals. Materials and methods Thirty Sprague-Dawley were divided into five groups (n=6) receiving the following treatments, respectively, p.o. for 15 consecutive days: distilled water, 0.75% v/v ethylene glycol + 2% w/v ammonium chloride, 0.75% v/v ethylene glycol + 2% w/v ammonium chloride + cystone® 750 mg/kg, 0.75% v/v ethylene glycol + 2% w/v ammonium chloride + diosmin 10 mg/kg or 0.75% v/v ethylene glycol + 2% w/v ammonium chloride + diosmin 20 mg/kg. Different biomarkers of urolithiasis in urine and serum were evaluated and histopathological examination of kidney was done. Results Animals treated with diosmin (both 10 and 20 mg/kg) had significantly (p < 0.005) decreased in kidney weight, urinary pH, total urinary protein, urinary calcium, phosphorus, serum potassium, sodium, magnesium, creatinine, uric acid and blood urea nitrogen levels and significantly (p < 0.005) increased in urinary volume, urinary magnesium, potassium, sodium, creatinine, uric acid and serum calcium levels in comparison to animals treated with ethylene glycol and ammonium chloride. However, results were better with diosmin 20 mg/kg in comparison to the control group. Conclusion Diosmin (10 and 20 mg/kg) has very good anti-urolithiatic activity similar to the standard drug cystone®.

Entities:  

Keywords:  Ammonium chloride; anti-urolithiatic effects; cystone; ethylene glycol; renal stone

Mesh:

Substances:

Year:  2016        PMID: 26799954     DOI: 10.3109/13880209.2015.1107105

Source DB:  PubMed          Journal:  Pharm Biol        ISSN: 1388-0209            Impact factor:   3.503


  6 in total

1.  Antiurolithic effects of medicinal plants: results of in vivo studies in rat models of calcium oxalate nephrolithiasis-a systematic review.

Authors:  Aslam Khan; Samra Bashir; Saeed R Khan
Journal:  Urolithiasis       Date:  2021-01-23       Impact factor: 3.436

2.  Flavonoid fractions of diosmin and hesperidin mitigate lead acetate-induced biochemical, oxidative stress, and histopathological alterations in Wistar rats.

Authors:  Ibrahim Yusuf Lamidi; Hudu Garba Mikail; Sani Adamu; Isaac Oluwatobi Akefe; Mohammed Bashir Tijjani; Sabo Isa Salihu; Aisha Omobolanle Olatunji; Abdussalam Hassan; Nubwa Daniel; Victoria Aderonke Adegoke
Journal:  Toxicol Res       Date:  2021-04-29

3.  A different perspective on the filtration barrier after kidney stone formation: An immunohistochemical and biochemical study.

Authors:  Derya Karabulut; Emin Kaymak; Betül Yalçin; Harun Ulger; Didem Barlak Keti
Journal:  Urolithiasis       Date:  2020-11-05       Impact factor: 3.436

Review 4.  Dietary Plants for the Prevention and Management of Kidney Stones: Preclinical and Clinical Evidence and Molecular Mechanisms.

Authors:  Mina Cheraghi Nirumand; Marziyeh Hajialyani; Roja Rahimi; Mohammad Hosein Farzaei; Stéphane Zingue; Seyed Mohammad Nabavi; Anupam Bishayee
Journal:  Int J Mol Sci       Date:  2018-03-07       Impact factor: 5.923

5.  Multi-targeting approach for nsp3, nsp9, nsp12 and nsp15 proteins of SARS-CoV-2 by Diosmin as illustrated by molecular docking and molecular dynamics simulation methodologies.

Authors:  Sumit Kumar; Prem Prakash Sharma; Charu Upadhyay; Prakasha Kempaiah; Brijesh Rathi
Journal:  Methods       Date:  2021-02-25       Impact factor: 3.608

6.  In Vitro Antilithiatic Potential of Kalanchoe pinnata, Emblica officinalis, Bambusa nutans, and Cynodon dactylon.

Authors:  Atul K Sohgaura; Papiya Bigoniya; B Shrivastava
Journal:  J Pharm Bioallied Sci       Date:  2018 Apr-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.